Basal insulin in combination with oral Hypoglycemic agents in the management of type 2 diabetes

被引：0
|
作者：
Springer, J [1 ]
机构：
[1] Scripps Clin, La Jolla, CA 92037 USA
来源：
DIABETES EDUCATOR | 2004年 / 30卷 / 01期
关键词：
D O I：
10.1177/014572170403000111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：68 / 70
页数：3
相关论文
共 50 条
  • [31] THE ROLE OF ORAL HYPOGLYCEMIC AGENTS IN MANAGEMENT OF TYPE 1 DIABETES; A PERSONAL CLINICAL EXPERIENCE
    Uwaifo, G., I
    Patel, S.
    Koch, C. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 352 - 352
  • [32] Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents
    Davis, Stephen N.
    Johns, Don
    Maggs, David
    Xu, Hangtao
    Northrup, Justin H.
    Brodows, Robert G.
    DIABETES CARE, 2007, 30 (11) : 2767 - 2772
  • [33] Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes
    Gougeon, R
    Jones, PJH
    Styhler, K
    Marliss, EB
    Morais, JA
    DIABETES CARE, 2000, 23 (01) : 1 - 8
  • [34] Pregnancy outcomes in women with type 2 diabetes treated with oral hypoglycemic agents
    Feghali, Maisa
    Mission, John
    Caritis, Steve
    Catov, Janet
    Scifres, Christina
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S339 - S339
  • [35] Depression in patients with type 2 diabetes: Impact on adherence to oral hypoglycemic agents
    Kalsekar, ID
    Madhavan, SS
    Amonkar, MM
    Makela, EH
    Scott, VG
    Douglas, SM
    Elswick, BLM
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 605 - 611
  • [36] Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China-Study Design and Baseline Characteristics
    Ji, Linong
    Zhang, Puhong
    Weng, Jianping
    Lu, Juming
    Guo, Xiaohui
    Jia, Weiping
    Yang, Wenying
    Zou, Dajin
    Zhou, Zhiguang
    Pan, Changyu
    Gao, Yan
    Li, Xian
    Zhu, Dongshan
    Li, Ying
    Wu, Yangfeng
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (10) : 735 - 744
  • [37] Determinants of failure of oral hypoglycemic agents in patients with type 2 diabetes mellitus
    DeValk, H
    VanLeeuwen, JT
    Blankestijn, HG
    DeBruin, HJ
    Erkelens, DW
    DIABETES, 1996, 45 : 964 - 964
  • [38] Adding insulin glargine to oral hypoglycemic agents in patients with type 2 diabetes markedly reduces insulin dose versus conventional insulin therapy
    Janka, H
    DIABETES, 2003, 52 : A449 - A449
  • [39] MANAGEMENT OF DIABETES .5. USING ORAL HYPOGLYCEMIC AGENTS
    LEVINE, R
    MAHLER, R
    MOSS, JM
    AMERICAN FAMILY PHYSICIAN/GP, 1970, 2 (03) : 99 - &
  • [40] A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents
    Ross, SA
    Zinman, B
    Campos, RV
    Strack, T
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 2001, 24 (06): : 292 - 298
12345